In recent years, there have been multiple breakthroughs in cancer immunotherapy, with
immune checkpoint inhibitors becoming the most promising treatment strategy. However …

Abstract CD155 (PVR/necl5/Tage4), a member of the nectin-like family of adhesion
molecules, is highly upregulated on tumor cells across multiple cancer types and has been …

CD155/T cell immunoreceptor with Ig and ITIM domains (TIGIT) is a novel type of immune
checkpoint. CD155 is an adhesion molecule that is upregulated during tumor progression …

CD155, also known as the poliovirus receptor, is an adhesion molecule often overexpressed
in tumors of different origins where it promotes cell migration and proliferation. In addition to …

The tumor microenvironment restricts the function and survival of various immune cells by up-
regulating inhibitory immune checkpoints, and participates in the immune escape of tumors …

Cluster of differentiation (CD155), formerly identified as poliovirus receptor (PVR) and later
as immunoglobulin molecule, is involved in cell adhesion, proliferation, invasion and …

CD155 is an adhesion molecule belonging to the Nectin/Nectin-like family often
overexpressed on tumor cells and involved in many different processes such as cell …

CD155, also known as the poliovirus receptor (PVR), has received considerable attention in
recent years because of its intrinsic and extrinsic roles in tumor progression. Although barely …

Simple Summary Some immunotherapies, such as anti-PD1 and anti-PD-L1 treatments,
have been used to treat various tumors. However, they are less efficient against esophageal …

The activating receptor CD226 is expressed on lymphocytes, monocytes, and platelets and
promotes anti-tumor immunity in pre-clinical models. Here, we examined the role of CD226 …